These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4154550)

  • 41. Murine mammary tumor virus protein vaccine: induction of antivirus immunity and inhibition or acceleration of growth of transplanted mammary tumors.
    Creemers P; Ouwehand J; Bentvelzen P
    J Natl Cancer Inst; 1977 Sep; 59(3):895-903. PubMed ID: 197247
    [No Abstract]   [Full Text] [Related]  

  • 42. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on skin allograft reaction in closed colony black hairy mice previously implanted with selected malignant tumors.
    Uchiyama M
    Yokohama Med Bull; 1971 Oct; 22(3):49-71. PubMed ID: 4946489
    [No Abstract]   [Full Text] [Related]  

  • 44. Immune reactivity of allogeneically pregnant mice to paternal MHC antigens on fetal and placental cells assessed by second set rejection of ascites tumor cells.
    Saito M; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Goto S; Tomoda Y
    J Reprod Immunol; 1985 Nov; 8(2-3):139-51. PubMed ID: 4093908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined effects of antineoplastic agents and anti-lymphoma allograft reactions.
    Riccardi C; Bartocci A; Puccetti P; Spreafico F; Bonmassar E; Goldin A
    Eur J Cancer (1965); 1980 Jan; 16(1):23-33. PubMed ID: 7358077
    [No Abstract]   [Full Text] [Related]  

  • 46. Time dependency of endotoxin-induced resistance to transplantable tumors in mice.
    Nowotny A; Moore ME; Nejman G; Nowotny AM
    Cancer Invest; 1987; 5(3):195-203. PubMed ID: 3308018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune response in tumor-bearing patients and animals. IV. Immunological competence in lymphoid cells of tumor-bearing mice.
    Sekiguchi M; Odaka T; Fujii G; Ishibashi Y
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):90-5. PubMed ID: 4392613
    [No Abstract]   [Full Text] [Related]  

  • 48. Early growth of experimental tumors and the onset of concomitant immunity.
    karakousis CP; Paolini NS; Sharma SD; Moore RH
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):211-7. PubMed ID: 6284514
    [No Abstract]   [Full Text] [Related]  

  • 49. Antigenic changes associated with resistance to methotrexate and 6-mercaptopurine in L1210 ascites lymphoma.
    Calman NS; Eng B; Slater LM; Wallerstein H
    J Natl Cancer Inst; 1974 Mar; 52(3):997-8. PubMed ID: 4826575
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 51. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

  • 52. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor-specific transplantation immunity after cryosurgery.
    Myers RS; Hammond WG; Ketcham AS
    J Surg Oncol; 1969; 1(3):241-6. PubMed ID: 5406367
    [No Abstract]   [Full Text] [Related]  

  • 54. Protection against syngeneic tumor grafts induced by inoculation with normal allogeneic tissues.
    Bear RH; Roholt OA; Pressman D
    Immunol Commun; 1977; 6(6):547-58. PubMed ID: 342393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of resistance to mammary tumor development in C57BL and I strains of mice. II. Inherent differences between the two strains.
    Nandi S
    J Natl Cancer Inst; 1974 Jun; 52(6):1797-804. PubMed ID: 4365389
    [No Abstract]   [Full Text] [Related]  

  • 57. Allograft reaction against H-2-region antigens.
    Klein J
    Transplant Proc; 1977 Mar; 9(1):847-52. PubMed ID: 17202
    [No Abstract]   [Full Text] [Related]  

  • 58. Augmentation of host resistance to Candida albicans infection in ascites tumor-bearing mice.
    Okawa Y; Murata Y; Kobayashi M; Suzuki M; Suzuki S
    Microbiol Immunol; 1992; 36(5):517-21. PubMed ID: 1513264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Active immunological enhancement of sarcoma 180 in splenectomized Swiss mice.
    Dosne Pasqualini C; Colmerauer ME
    Biomedicine; 1976 Jul; 25(6):202-4. PubMed ID: 963183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The response of C3H mice to an L1210 tumor allograft.
    Nevalainen DE
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):771-4. PubMed ID: 4828768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.